ID   CDK2_RAT                Reviewed;         298 AA.
AC   Q63699; O09136;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   02-OCT-2024, entry version 177.
DE   RecName: Full=Cyclin-dependent kinase 2;
DE            EC=2.7.11.22 {ECO:0000269|PubMed:10542199};
DE   AltName: Full=Cell division protein kinase 2;
GN   Name=Cdk2; Synonyms=Cdkn2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Thyroid;
RX   PubMed=7862443;
RA   Kotani S., Endo T., Kitagawa M., Higashi H., Onaya T.;
RT   "A variant form of cyclin-dependent kinase 2 (Cdk2) in a malignantly
RT   transformed rat thyroid (FRTL-Tc) cell line.";
RL   Oncogene 10:663-669(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 19-124.
RX   PubMed=8673024;
RA   Hosokawa Y., Yang M., Kaneko S., Tanaka M., Nakashima K.;
RT   "Synergistic gene expressions of cyclin E, cdk2, cdk5 and E2F-1 during the
RT   prolactin-induced G1/S transition in rat Nb2 pre-T lymphoma cells.";
RL   Biochem. Mol. Biol. Int. 37:393-399(1995).
RN   [3]
RP   FUNCTION AS RB1 KINASE, CATALYTIC ACTIVITY, INDUCTION BY TGFB1, AND
RP   INTERACTION WITH RB1.
RX   PubMed=10542199; DOI=10.1074/jbc.274.45.31775;
RA   Choi K.S., Eom Y.W., Kang Y., Ha M.J., Rhee H., Yoon J.-W., Kim S.-J.;
RT   "Cdc2 and Cdk2 kinase activated by transforming growth factor-beta1 trigger
RT   apoptosis through the phosphorylation of retinoblastoma protein in FaO
RT   hepatoma cells.";
RL   J. Biol. Chem. 274:31775-31783(1999).
CC   -!- FUNCTION: Serine/threonine-protein kinase involved in the control of
CC       the cell cycle; essential for meiosis, but dispensable for mitosis (By
CC       similarity). Phosphorylates CABLES1, CTNNB1, CDK2AP2, ERCC6, NBN,
CC       USP37, p53/TP53, NPM1, CDK7, RB1, BRCA2, MYC, NPAT, EZH2
CC       (PubMed:10542199). Triggers duplication of centrosomes and DNA (By
CC       similarity). Acts at the G1-S transition to promote the E2F
CC       transcriptional program and the initiation of DNA synthesis, and
CC       modulates G2 progression; controls the timing of entry into
CC       mitosis/meiosis by controlling the subsequent activation of cyclin
CC       B/CDK1 by phosphorylation, and coordinates the activation of cyclin
CC       B/CDK1 at the centrosome and in the nucleus (By similarity). Crucial
CC       role in orchestrating a fine balance between cellular proliferation,
CC       cell death, and DNA repair in embryonic stem cells (ESCs) (By
CC       similarity). Activity of CDK2 is maximal during S phase and G2;
CC       activated by interaction with cyclin E during the early stages of DNA
CC       synthesis to permit G1-S transition, and subsequently activated by
CC       cyclin A2 (cyclin A1 in germ cells) during the late stages of DNA
CC       replication to drive the transition from S phase to mitosis, the G2
CC       phase (By similarity). EZH2 phosphorylation promotes H3K27me3
CC       maintenance and epigenetic gene silencing (By similarity). Cyclin
CC       E/CDK2 prevents oxidative stress-mediated Ras-induced senescence by
CC       phosphorylating MYC (By similarity). Involved in G1-S phase DNA damage
CC       checkpoint that prevents cells with damaged DNA from initiating
CC       mitosis; regulates homologous recombination-dependent repair by
CC       phosphorylating BRCA2, this phosphorylation is low in S phase when
CC       recombination is active, but increases as cells progress towards
CC       mitosis (By similarity). In response to DNA damage, double-strand break
CC       repair by homologous recombination a reduction of CDK2-mediated BRCA2
CC       phosphorylation (By similarity). Involved in regulation of telomere
CC       repair by mediating phosphorylation of NBN (By similarity).
CC       Phosphorylation of RB1 disturbs its interaction with E2F1 (By
CC       similarity). NPM1 phosphorylation by cyclin E/CDK2 promotes its
CC       dissociation from unduplicated centrosomes, thus initiating centrosome
CC       duplication (By similarity). Cyclin E/CDK2-mediated phosphorylation of
CC       NPAT at G1-S transition and until prophase stimulates the NPAT-mediated
CC       activation of histone gene transcription during S phase (By
CC       similarity). Required for vitamin D-mediated growth inhibition by being
CC       itself inactivated (By similarity). Involved in the nitric oxide- (NO)
CC       mediated signaling in a nitrosylation/activation-dependent manner (By
CC       similarity). USP37 is activated by phosphorylation and thus triggers
CC       G1-S transition (By similarity). CTNNB1 phosphorylation regulates
CC       insulin internalization (By similarity). Phosphorylates FOXP3 and
CC       negatively regulates its transcriptional activity and protein stability
CC       (By similarity). Phosphorylates ERCC6 which is essential for its
CC       chromatin remodeling activity at DNA double-strand breaks (By
CC       similarity). {ECO:0000250|UniProtKB:P24941,
CC       ECO:0000250|UniProtKB:P97377, ECO:0000269|PubMed:10542199}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.22;
CC         Evidence={ECO:0000269|PubMed:10542199};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.22; Evidence={ECO:0000269|PubMed:10542199};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:P24941};
CC       Note=Binds 2 Mg(2+) ions. {ECO:0000250|UniProtKB:P24941};
CC   -!- ACTIVITY REGULATION: Phosphorylation at Thr-14 or Tyr-15 inactivates
CC       the enzyme, while phosphorylation at Thr-160 activates it. Stimulated
CC       by MYC. Inactivated by CDKN1A (p21) (By similarity).
CC       {ECO:0000250|UniProtKB:P24941}.
CC   -!- SUBUNIT: Found in a complex with CABLES1, CCNA1 and CCNE1. Interacts
CC       with CABLES1 (By similarity). Interacts with UHRF2. Part of a complex
CC       consisting of UHRF2, CDK2 and CCNE1. Interacts with the Speedy/Ringo
CC       proteins SPDYA and SPDYC. Interaction with SPDYA promotes kinase
CC       activation via a conformation change that alleviates obstruction of the
CC       substrate-binding cleft by the T-loop. Found in a complex with both
CC       SPDYA and CDKN1B/KIP1. Binds to RB1 (PubMed:10542199). Binds to CDK7.
CC       Binding to CDKN1A (p21) leads to CDK2/cyclin E inactivation at the G1-S
CC       phase DNA damage checkpoint, thereby arresting cells at the G1-S
CC       transition during DNA repair. Associated with PTPN6 and beta-
CC       catenin/CTNNB1. Interacts with CACUL1. May interact with CEP63.
CC       Interacts with ANKRD17. Interacts with CEBPA (when phosphorylated).
CC       Forms a ternary complex with CCNA2 and CDKN1B; CDKN1B inhibits the
CC       kinase activity of CDK2 through conformational rearrangements.
CC       Interacts with cyclins A, B1, B3, D, or E. Interacts with CDK2AP2 (By
CC       similarity). {ECO:0000250|UniProtKB:P24941,
CC       ECO:0000250|UniProtKB:P97377, ECO:0000269|PubMed:10542199}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, microtubule organizing
CC       center, centrosome {ECO:0000250}. Nucleus, Cajal body {ECO:0000250}.
CC       Cytoplasm {ECO:0000250}. Endosome {ECO:0000250}. Note=Localized at the
CC       centrosomes in late G2 phase after separation of the centrosomes but
CC       before the start of prophase. Nuclear-cytoplasmic trafficking is
CC       mediated during the inhibition by 1,25-(OH)(2)D(3) (By similarity).
CC       {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=CDK2-alpha;
CC         IsoId=Q63699-1; Sequence=Displayed;
CC       Name=CDK2-beta;
CC         IsoId=Q63699-2; Sequence=Not described;
CC   -!- INDUCTION: Induced transiently by TGFB1 at an early phase of TGFB1-
CC       mediated apoptosis. {ECO:0000269|PubMed:10542199}.
CC   -!- PTM: Phosphorylated at Thr-160 by CDK7 in a CAK complex.
CC       Phosphorylation at Thr-160 promotes kinase activity, whereas
CC       phosphorylation at Tyr-15 by WEE1 reduces slightly kinase activity.
CC       Phosphorylated on Thr-14 and Tyr-15 during S and G2 phases before being
CC       dephosphorylated by CDC25A. {ECO:0000250|UniProtKB:P24941}.
CC   -!- PTM: Nitrosylated after treatment with nitric oxide (DETA-NO).
CC       {ECO:0000250|UniProtKB:P24941}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC Ser/Thr
CC       protein kinase family. CDC2/CDKX subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D28753; BAA05947.1; -; mRNA.
DR   EMBL; D63162; BAA09638.1; -; mRNA.
DR   AlphaFoldDB; Q63699; -.
DR   SMR; Q63699; -.
DR   ComplexPortal; CPX-2067; Cyclin A1-CDK2 complex.
DR   ComplexPortal; CPX-2068; Cyclin A2-CDK2 complex.
DR   ComplexPortal; CPX-2083; Cyclin E1-CDK2 complex.
DR   ComplexPortal; CPX-2084; Cyclin E2-CDK2 complex.
DR   DIP; DIP-36536N; -.
DR   IntAct; Q63699; 2.
DR   STRING; 10116.ENSRNOP00000032191; -.
DR   iPTMnet; Q63699; -.
DR   PhosphoSitePlus; Q63699; -.
DR   jPOST; Q63699; -.
DR   PaxDb; 10116-ENSRNOP00000032191; -.
DR   UCSC; RGD:70486; rat. [Q63699-1]
DR   AGR; RGD:70486; -.
DR   RGD; 70486; Cdk2.
DR   eggNOG; KOG0594; Eukaryota.
DR   InParanoid; Q63699; -.
DR   PhylomeDB; Q63699; -.
DR   BRENDA; 2.7.11.22; 5301.
DR   Reactome; R-RNO-1538133; G0 and Early G1.
DR   Reactome; R-RNO-171319; Telomere Extension By Telomerase.
DR   Reactome; R-RNO-176187; Activation of ATR in response to replication stress.
DR   Reactome; R-RNO-176408; Regulation of APC/C activators between G1/S and early anaphase.
DR   Reactome; R-RNO-187577; SCF(Skp2)-mediated degradation of p27/p21.
DR   Reactome; R-RNO-2559582; Senescence-Associated Secretory Phenotype (SASP).
DR   Reactome; R-RNO-2559586; DNA Damage/Telomere Stress Induced Senescence.
DR   Reactome; R-RNO-5693607; Processing of DNA double-strand break ends.
DR   Reactome; R-RNO-6804116; TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest.
DR   Reactome; R-RNO-6804756; Regulation of TP53 Activity through Phosphorylation.
DR   Reactome; R-RNO-6804757; Regulation of TP53 Degradation.
DR   Reactome; R-RNO-68911; G2 Phase.
DR   Reactome; R-RNO-68949; Orc1 removal from chromatin.
DR   Reactome; R-RNO-68962; Activation of the pre-replicative complex.
DR   Reactome; R-RNO-69017; CDK-mediated phosphorylation and removal of Cdc6.
DR   Reactome; R-RNO-69200; Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes.
DR   Reactome; R-RNO-69202; Cyclin E associated events during G1/S transition.
DR   Reactome; R-RNO-69231; Cyclin D associated events in G1.
DR   Reactome; R-RNO-69273; Cyclin A/B1/B2 associated events during G2/M transition.
DR   Reactome; R-RNO-69563; p53-Dependent G1 DNA Damage Response.
DR   Reactome; R-RNO-69656; Cyclin A:Cdk2-associated events at S phase entry.
DR   Reactome; R-RNO-8849470; PTK6 Regulates Cell Cycle.
DR   Reactome; R-RNO-9616222; Transcriptional regulation of granulopoiesis.
DR   PRO; PR:Q63699; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0015030; C:Cajal body; ISO:RGD.
DR   GO; GO:0005813; C:centrosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0000781; C:chromosome, telomeric region; ISO:RGD.
DR   GO; GO:0000793; C:condensed chromosome; ISO:RGD.
DR   GO; GO:0097123; C:cyclin A1-CDK2 complex; ISO:RGD.
DR   GO; GO:0097124; C:cyclin A2-CDK2 complex; ISO:RGD.
DR   GO; GO:0097134; C:cyclin E1-CDK2 complex; ISO:RGD.
DR   GO; GO:0097135; C:cyclin E2-CDK2 complex; ISO:RGD.
DR   GO; GO:0000307; C:cyclin-dependent protein kinase holoenzyme complex; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005768; C:endosome; ISO:RGD.
DR   GO; GO:0001673; C:male germ cell nucleus; ISO:RGD.
DR   GO; GO:0005635; C:nuclear envelope; ISO:RGD.
DR   GO; GO:0005654; C:nucleoplasm; ISO:RGD.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0005667; C:transcription regulator complex; ISO:RGD.
DR   GO; GO:0000805; C:X chromosome; ISO:RGD.
DR   GO; GO:0000806; C:Y chromosome; ISO:RGD.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0030332; F:cyclin binding; IPI:RGD.
DR   GO; GO:0097472; F:cyclin-dependent protein kinase activity; ISO:RGD.
DR   GO; GO:0004693; F:cyclin-dependent protein serine/threonine kinase activity; IDA:RGD.
DR   GO; GO:0016301; F:kinase activity; ISO:RGD.
DR   GO; GO:0000287; F:magnesium ion binding; ISO:RGD.
DR   GO; GO:0019904; F:protein domain specific binding; ISO:RGD.
DR   GO; GO:0004672; F:protein kinase activity; ISO:RGD.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; ISO:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; IPI:RGD.
DR   GO; GO:0031100; P:animal organ regeneration; IEP:RGD.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0032869; P:cellular response to insulin stimulus; IDA:RGD.
DR   GO; GO:0007099; P:centriole replication; ISO:RGD.
DR   GO; GO:0006338; P:chromatin remodeling; IEA:GOC.
DR   GO; GO:0006974; P:DNA damage response; IMP:RGD.
DR   GO; GO:0006281; P:DNA repair; IEA:UniProtKB-KW.
DR   GO; GO:0006351; P:DNA-templated transcription; ISO:RGD.
DR   GO; GO:0000082; P:G1/S transition of mitotic cell cycle; ISO:RGD.
DR   GO; GO:0002088; P:lens development in camera-type eye; IEP:RGD.
DR   GO; GO:0051321; P:meiotic cell cycle; IEA:UniProtKB-KW.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:0032298; P:positive regulation of DNA-templated DNA replication initiation; ISO:RGD.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0031453; P:positive regulation of heterochromatin formation; ISO:RGD.
DR   GO; GO:0043687; P:post-translational protein modification; ISO:RGD.
DR   GO; GO:0006813; P:potassium ion transport; ISO:RGD.
DR   GO; GO:0007265; P:Ras protein signal transduction; ISO:RGD.
DR   GO; GO:0010389; P:regulation of G2/M transition of mitotic cell cycle; IBA:GO_Central.
DR   GO; GO:0010468; P:regulation of gene expression; IBA:GO_Central.
DR   GO; GO:0046686; P:response to cadmium ion; IEP:RGD.
DR   GO; GO:0051591; P:response to cAMP; IDA:RGD.
DR   GO; GO:0051602; P:response to electrical stimulus; IDA:RGD.
DR   GO; GO:0032355; P:response to estradiol; IEP:RGD.
DR   GO; GO:0045471; P:response to ethanol; IEP:RGD.
DR   GO; GO:0009636; P:response to toxic substance; IEP:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IEP:RGD.
DR   GO; GO:0007165; P:signal transduction; IBA:GO_Central.
DR   GO; GO:0043247; P:telomere maintenance in response to DNA damage; ISO:RGD.
DR   CDD; cd07860; STKc_CDK2_3; 1.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR050108; CDK.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   PANTHER; PTHR24056; CELL DIVISION PROTEIN KINASE; 1.
DR   PANTHER; PTHR24056:SF521; CYCLIN-DEPENDENT KINASE 2; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; ATP-binding; Cell cycle; Cell division;
KW   Cytoplasm; Cytoskeleton; DNA damage; DNA repair; Endosome; Kinase;
KW   Magnesium; Meiosis; Metal-binding; Mitosis; Nucleotide-binding; Nucleus;
KW   Phosphoprotein; Reference proteome; Serine/threonine-protein kinase;
KW   Transferase.
FT   CHAIN           1..298
FT                   /note="Cyclin-dependent kinase 2"
FT                   /id="PRO_0000085772"
FT   DOMAIN          4..286
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   ACT_SITE        127
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         10..18
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         33
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         81..83
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         86
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         129..132
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         132
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250|UniProtKB:P24941"
FT   BINDING         145
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         145
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250|UniProtKB:P24941"
FT   SITE            9
FT                   /note="CDK7 binding"
FT                   /evidence="ECO:0000250|UniProtKB:P24941"
FT   SITE            88..89
FT                   /note="CDK7 binding"
FT                   /evidence="ECO:0000250|UniProtKB:P24941"
FT   SITE            166
FT                   /note="CDK7 binding"
FT                   /evidence="ECO:0000250|UniProtKB:P24941"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000250|UniProtKB:P24941"
FT   MOD_RES         6
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P24941"
FT   MOD_RES         14
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P24941"
FT   MOD_RES         15
FT                   /note="Phosphotyrosine; by WEE1"
FT                   /evidence="ECO:0000250|UniProtKB:P24941"
FT   MOD_RES         19
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P24941"
FT   MOD_RES         160
FT                   /note="Phosphothreonine; by CAK and CCRK"
FT                   /evidence="ECO:0000250|UniProtKB:P24941"
FT   CONFLICT        79
FT                   /note="V -> C (in Ref. 2; BAA09638)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        99
FT                   /note="L -> I (in Ref. 2; BAA09638)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        124
FT                   /note="L -> C (in Ref. 2; BAA09638)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   298 AA;  33887 MW;  C8CB3ADCE9B97F88 CRC64;
     MENFQKVEKI GEGTYGVVYK AKNKLTGEVV ALKKIRLDTE TEGVPSTAIR EISLLKELNH
     PNIVKLLDVI HTENKLYLVF EFLHQDLKKF MDASALTGLP LPLIKSYLFQ LLQGLAFCHS
     HRVLHRDLKP QNLLINAEGS IKLADFGLAR AFGVPVRTYT HEVVTLWYRA PEILLGCKYY
     STAVDIWSLG CIFAEMVTRR ALFPGDSEID QLFRIFRTLG TPDEVVWPGV TSMPDYKPSF
     PKWARQDFSK VVPPLDEDGR SLLSQMLHYD PNKRISAKAA LAHPFFQDVT KPVPHLRL
//
